Regenerative Medical Technology (RMTG) Inventory Average (2024 - 2026)
Regenerative Medical Technology (RMTG) posted quarterly Inventory Average of $228739.0 for Q1 2026, up 1288.65% year-over-year from $16472.0 in Q1 2025, and up 45.16% quarter-over-quarter from $157581.5 in Q4 2025.
Regenerative Medical Technology (RMTG) Inventory Average (2024 - 2026) Analysis & Trends
Regenerative Medical Technology's Inventory Average history runs 3 years deep, the most recent figure standing at $228739.0 for Q1 2026.
- In Q1 2026, Inventory Average rose 1288.65% year-over-year to $228739.0; the TTM figure through Mar 2026 stood at $228739.0 (up 1288.65% YoY), while the FY2025 annual figure was $84696.0, changed N/A from the prior year.
- Inventory Average for Q1 2026 stood at $228739.0, up from $157581.5 in the prior quarter.
- The five-year high for Inventory Average was $228739.0 in Q1 2026, with the low at $6680.0 in Q3 2024.
- The 3-year median for Inventory Average is $64258.5 (2025), against an average of $87559.4.
- The sharpest annual moves came in 2025 and 2026: Inventory Average soared 1857.89% in 2025, then surged 1288.65% in 2026.
- Regenerative Medical Technology's Inventory Average stood at $8397.5 in 2024, then soared by 1776.53% to $157581.5 in 2025, then surged by 45.16% to $228739.0 in 2026.
- Business Quant data shows RMTG's Inventory Average at $228739.0 in Q1 2026, $157581.5 in Q4 2025, and $130787.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | 213.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 707.10 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 90.57 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 137.65 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 196.36 Mn |
| 10 | Regenerative Medical Technology | 961,772.49 | -99,675.51 | 1.77 Mn | 228,739.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 228,739.00 |
| Dec 31, 2025 | 157,581.50 |
| Sep 30, 2025 | 130,787.00 |
| Jun 30, 2025 | 64,258.50 |
| Mar 31, 2025 | 16,472.00 |
| Dec 31, 2024 | 8,397.50 |
| Sep 30, 2024 | 6,680.00 |